V Breu - JoVE Visualize

Showing results (31-40 of 46) with videos related to

Pageof 5

Sort By:

European Journal of Biochemistry|July 1, 1995

Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptorsV Breu, K Hashido, C Broger, et al.

Hypertension (Dallas, Tex. : 1979)|February 19, 2000

Blood pressure-independent effects in rats with human renin and angiotensinogen genesE Mervaala, D N Müller, F Schmidt, et al.

Hypertension (Dallas, Tex. : 1979)|March 7, 2001

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injuryA Fiebeler, F Schmidt, D N Müller, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonistM Clozel, V Breu, G A Gray, et al.

Nature|October 21, 1993

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistM Clozel, V Breu, K Burri, et al.

Hypertension (Dallas, Tex. : 1979)|February 4, 1999

Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertensionE M Mervaala, D N Müller, J K Park, et al.

Protein Expression and Purification|February 1, 1996

Recombinant human renin produced in different expression systems: biochemical properties and 3D structureS Mathews, H Döbeli, M Pruschy, et al.

Hypertension (Dallas, Tex. : 1979)|January 21, 2000

Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genesE Mervaala, D N Müller, J K Park, et al.

Hypertension (Dallas, Tex. : 1979)|January 21, 2000

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in ratsD N Muller, R Dechend, E M Mervaala, et al.

Hypertension (Dallas, Tex. : 1979)|August 19, 2000

Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damageD N Muller, E M Mervaala, F Schmidt, et al.

Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:

Pageof 5

European Journal of Biochemistry|July 1, 1995

Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptorsV Breu, K Hashido, C Broger, et al.

Hypertension (Dallas, Tex. : 1979)|February 19, 2000

Blood pressure-independent effects in rats with human renin and angiotensinogen genesE Mervaala, D N Müller, F Schmidt, et al.

Hypertension (Dallas, Tex. : 1979)|March 7, 2001

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injuryA Fiebeler, F Schmidt, D N Müller, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonistM Clozel, V Breu, G A Gray, et al.

Nature|October 21, 1993

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistM Clozel, V Breu, K Burri, et al.

Hypertension (Dallas, Tex. : 1979)|February 4, 1999

Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertensionE M Mervaala, D N Müller, J K Park, et al.

Protein Expression and Purification|February 1, 1996

Recombinant human renin produced in different expression systems: biochemical properties and 3D structureS Mathews, H Döbeli, M Pruschy, et al.

Hypertension (Dallas, Tex. : 1979)|January 21, 2000

Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genesE Mervaala, D N Müller, J K Park, et al.

Hypertension (Dallas, Tex. : 1979)|January 21, 2000

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in ratsD N Muller, R Dechend, E M Mervaala, et al.

Hypertension (Dallas, Tex. : 1979)|August 19, 2000

Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damageD N Muller, E M Mervaala, F Schmidt, et al.

Pageof 5